Ensign Peak Advisors
AGL icon

Ensign Peak Advisors’s Agilon Health AGL Stock Holding History

Ensign Peak Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,637
Closed -$554K – 1709
2024
Q3 		$554K Hold
5,637
– – ﹤0.01% 1578
2024
Q2 		$922K Buy
5,637
+1,710
+44% +$244K ﹤0.01% 1331
2024
Q1 		$599K Sell
3,927
-199
-5% -$33.1K ﹤0.01% 1582
2023
Q4 		$1.29M Buy
4,126
+934
+29% +$338K ﹤0.01% 1181
2023
Q3 		$1.42M Buy
3,192
+478
+18% +$216K ﹤0.01% 958
2023
Q2 		$1.18M Hold
2,714
– – ﹤0.01% 1135
2023
Q1 		$1.61M Hold
2,714
– – ﹤0.01% 934
2022
Q4 		$1.09M Buy
2,714
+878
+48% +$412K ﹤0.01% 1091
2022
Q3 		$1.07M Buy
+1,836
New +$1.1M ﹤0.01% 1032

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ensign Peak Advisors's AGL Position: Q4 2024 in Review

Ensign Peak Advisors sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 5,637 shares — an estimated $554K sold.

Ensign Peak Advisors first reported a position in AGL in Q3 2022 and held it in 9 quarters. The position peaked at $1.61M in Q1 2023. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

  • Ensign Peak Advisors reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 5,637 Agilon Health shares in Q4 2024, an estimated $554K.
  • Ensign Peak Advisors first reported a position in Agilon Health in Q3 2022 and held it in 9 quarters.
  • Ensign Peak Advisors's Agilon Health position peaked at $1.61M in Q1 2023.
  • 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.